Cart (0 Items)
Your cart is currently empty.
View ProductsBlinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | (scFv-kappa-heavy)-(scFv-heavy-kappa); His-Tag |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade |
|---|---|
| Source | CAS 853426-35-4 |
| Species | Mus musculus |
| Expression system | Mammalian cells |
| Molecular weight | 54.1kDa |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Blinatumomab,AMG103,BITE MT-103,MEDI-538,MT103,bscCD19xCD3,CD19, CD3E,anti-CD19, CD3E |
| Reference | PX-TA1067 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | (scFv-kappa-heavy)-(scFv-heavy-kappa); His-Tag |
| Clonality | Monoclonal Antibody |
Description of Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
General information on Anti-CD19/CD3E(Homo sapiens) (Blinatumomab) Monoclonal Antibody
Blinatumomab is a monoclonal antibody constructed by BiTE (bispecific T cell engagers), which is used to treat relapsed or refractory B cell precursor acute lymphoblastic leukemia (ALL) with negative Philadelphia chromosome. Blinatumomab is available as a drug under the Blincyto™ brand.
SDS-PAGE for Blinatumomab Biosimilar - Anti-CD19, CD3E mAb
Blinatumomab Biosimilar - Anti-CD19, CD3E mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Antigen
CD19 Protein – Human CD19 recombinant protein
PX-P4004 210€
Antigen
CD3E Recombinant Protein
PX-P4075 420€
Antigen
CD19 Recombinant Protein
PX-P4077 420€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.